Editas Medicine
EDIT
$5.35
Share price
-2.01%
Change (1 day)
-32.02%
Change (1 year)
Earnings for Editas Medicine (EDIT)
Earnings in 2023 (TTM): -$0.17 B
According to Editas Medicine 's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.23 B a decrease over its 2021 earnings that were of -$0.2 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Editas Medicine from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.17 B | -25.13% |
| 2022 | -$0.23 B | 16.98% |
| 2021 | -$0.2 B | 43.24% |
| 2020 | -$0.14 B | -4.41% |
| 2019 | -$0.15 B | 24.39% |
| 2018 | -$0.12 B | -4.98% |
| 2017 | -$0.12 B | 22.73% |
| 2016 | -$97.25 M | 172.88% |
| 2015 | -$35.64 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -88.72% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | -56.81% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 212.46% | 🇺🇸 USA |
 Novocure
NVCR | -$0.19 B | 11.37% | Jersey |